In individuals with type 2 diabetes mellitus (T2DM) [9], the incretin effect is markedly impaired, with GLP-1 activity being preserved but diminished, and GIP activity being significantly reduced [10]. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.